Patent · US Active

Benzimidazole derivatives

US8119675B2 · kind B2 · utility

0Cited by

3References

19Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Lars Burgdorf · Frankfurt am Main, DE
Bertram Cezanne · Mörfelden, DE
Markus Klein · Weiterstadt, DE
Rolf Gericke · Seeheim-Jugenheim, DE
Christos Tsaklakidis · Weinheim, DE
Werner Mederski · Zwingenberg, DE
Norbert Beier · Reinheim, DE

Key dates

Filing date	Jan 28, 2008
Grant date	Feb 21, 2012
Priority date	—
Expiry date	Jun 21, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel compounds of the formula I (I), in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R, Q, W, X and Z have the meanings indicated in Patent Claim 1, are suitable as antidiabetics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.